Wednesday, May 16, 2018 11:29:39 AM
I believed in BVTK for a long time, but it looks like Mr. Cellucci is just faking it. All these empty promises about revenues. Currently there are more MAP partners and "deals" full of air then revenues. Looking at the FORM 12b-25 filing they are not expecting any significant changes. So I should not expect any good revenue numbers for Q1....
Ofcourse we already knew that because when there was revenue they didn't need additional convertible debt which we have seen in the subsequent evensts on the 10-K.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM